Log in to your account:
Bristol-Myers Squibb (BMY) Provides Update on Pending Transaction with Celgene (CELG), Says Remains on Track to Close in Q3
February 20, 2019 9:02 AM
Bristol-Myers Squibb Company (NYSE: BMY) today provided an update on its proposed acquisition of Celgene Corporation (NASDAQ: CELG). Bristol-Myers Squibb ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Mergers and Acquisitions
Bristol-Myers Squibb Provides Update on Pending Transaction with Celgene
February 20, 2019 9:00 AM